Lance David Miller
Lance David Miller
Associate professor of Cancer Biology, Wake Forest School of Medicine
Geverifieerd e-mailadres voor wakehealth.edu
Titel
Geciteerd door
Geciteerd door
Jaar
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival
LD Miller, J Smeds, J George, VB Vega, L Vergara, A Ploner, Y Pawitan, ...
Proceedings of the National Academy of Sciences 102 (38), 13550-13555, 2005
13902005
A global map of p53 transcription-factor binding sites in the human genome
CL Wei, Q Wu, VB Vega, KP Chiu, P Ng, T Zhang, A Shahab, HC Yong, ...
Cell 124 (1), 207-219, 2006
13152006
High-fidelity mRNA amplification for gene profiling
E Wang, LD Miller, GA Ohnmacht, ET Liu, FM Marincola
Nature biotechnology 18 (4), 457-459, 2000
8662000
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts
Y Pawitan, J Bjöhle, L Amler, AL Borg, S Egyhazi, P Hall, X Han, ...
Breast cancer research 7 (6), 1-12, 2005
8392005
Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer
AV Ivshina, J George, O Senko, B Mow, TC Putti, J Smeds, T Lindahl, ...
Cancer research 66 (21), 10292-10301, 2006
7462006
Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-κB-responsive genes in cervical keratinocytes
M Nees, JM Geoghegan, T Hyman, S Frank, L Miller, CD Woodworth
Journal of virology 75 (9), 4283-4296, 2001
4422001
Ferroportin and iron regulation in breast cancer progression and prognosis
ZK Pinnix, LD Miller, W Wang, R D’Agostino, T Kute, MC Willingham, ...
Science translational medicine 2 (43), 43ra56-43ra56, 2010
3782010
Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer
CN Landen, B Goodman, AA Katre, AD Steg, AM Nick, RL Stone, ...
Molecular cancer therapeutics 9 (12), 3186-3199, 2010
3732010
Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients
S Calza, P Hall, G Auer, J Bjöhle, S Klaar, U Kronenwett, ET Liu, L Miller, ...
Breast Cancer Research 8 (4), 1-9, 2006
3492006
Transcriptome analysis of zebrafish embryogenesis using microarrays
S Mathavan, SGP Lee, A Mak, LD Miller, KRK Murthy, KR Govindarajan, ...
PLoS genetics 1 (2), e29, 2005
3332005
Discovery of estrogen receptor α target genes and response elements in breast tumor cells
CY Lin, A Ström, VB Vega, SL Kong, AL Yeo, JS Thomsen, WC Chan, ...
Genome biology 5 (9), 1-18, 2004
3172004
Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression
SH Lam, YL Wu, VB Vega, LD Miller, J Spitsbergen, Y Tong, H Zhan, ...
Nature biotechnology 24 (1), 73-75, 2006
3052006
Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness
E Wang, LD Miller, GA Ohnmacht, S Mocellin, A Perez-Diez, D Petersen, ...
Cancer research 62 (13), 3581-3586, 2002
3022002
Identification of cell cycle-regulated genes in fission yeast
X Peng, RKM Karuturi, LD Miller, K Lin, Y Jia, P Kondu, L Wang, LS Wong, ...
Molecular biology of the cell 16 (3), 1026-1042, 2005
2152005
Optimal gene expression analysis by microarrays
LD Miller, PM Long, L Wong, S Mukherjee, LM McShane, ET Liu
Cancer cell 2 (5), 353-361, 2002
2042002
Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling
SW Nam, JY Park, A Ramasamy, S Shevade, A Islam, PM Long, CK Park, ...
Hepatology 42 (4), 809-818, 2005
1942005
Sal‐like protein 4 (SALL4), a stem cell biomarker in liver cancers
T Oikawa, A Kamiya, M Zeniya, H Chikada, AD Hyuck, Y Yamazaki, ...
Hepatology 57 (4), 1469-1483, 2013
1912013
Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome
J Frasor, EC Chang, B Komm, CY Lin, VB Vega, ET Liu, LD Miller, ...
Cancer research 66 (14), 7334-7340, 2006
1882006
An iron regulatory gene signature predicts outcome in breast cancer
LD Miller, LG Coffman, JW Chou, MA Black, J Bergh, R D'Agostino, ...
Cancer research 71 (21), 6728-6737, 2011
1802011
CDKN1C (p57KIP2) Is a Direct Target of EZH2 and Suppressed by Multiple Epigenetic Mechanisms in Breast Cancer Cells
X Yang, RKM Karuturi, F Sun, M Aau, K Yu, R Shao, LD Miller, PBO Tan, ...
PloS one 4 (4), e5011, 2009
1772009
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20